#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15836	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2194	717.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	930	C,T	874,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29036	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3615	800.7	0	.	n	.	0	T695C	SNP	695	695	T	1031	1031	C	894	C	845	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29036	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3615	800.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1673	1673	A	947	A	891	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29036	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3615	800.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2307	2307	C	950	C,T,A	876,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29036	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3615	800.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2933	2933	T	893	T,C	658,189	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29036	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3615	800.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2381	2381	A	933	A	870	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2256	folP	852	852	100.0	folP.l15.c17.ctg.1	1499	149.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1014	1016	AGC	244;244;243	A;G;C	224;225;224	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6074	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3454	175.2	1	SNP	p	S91F	0	.	.	271	273	TCC	497	499	TCC	234;233;232	T;C;C	217;219;216	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6074	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3454	175.2	1	SNP	p	D95G	0	.	.	283	285	GAC	509	511	GAC	234;237;238	G,A;A;C	216,1;218;220	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6074	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3454	175.2	1	SNP	p	D95N	0	.	.	283	285	GAC	509	511	GAC	234;237;238	G,A;A;C	216,1;218;220	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1860	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1230	149.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	378	380	ACC	234;236;235	A,G;C;C	209,1;219;217	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1860	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1230	149.9	0	.	p	.	0	R44H	NONSYN	130	132	CGC	393	395	CAC	233;231;235	C;A,G;C	219;212,1;221	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1860	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1230	149.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	576	578	CAC	236;235;234	C;A;C	227;224;223	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1860	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1230	149.9	1	SNP	p	G45D	0	.	.	133	135	GGC	396	398	GGC	238;240;242	G,A;G;C	222,1;220;227	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1036	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	928	110.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3005	192.3	1	SNP	p	D86N	0	.	.	256	258	GAC	699	701	GAC	240;237;239	G;A;C	233;225;231	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3005	192.3	1	SNP	p	S87I	0	.	.	259	261	AGT	702	704	AGT	240;243;242	A;G;T	232;234;233	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3005	192.3	1	SNP	p	S87R	0	.	.	259	261	AGT	702	704	AGT	240;243;242	A;G;T	232;234;233	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3005	192.3	1	SNP	p	S87W	0	.	.	259	261	AGT	702	704	AGT	240;243;242	A;G;T	232;234;233	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5798	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3005	192.3	1	SNP	p	S88P	0	.	.	262	264	TCC	705	707	TCC	240;242;245	T,A;C;C	231,1;232;236	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4972	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2751	180.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1656	1658	GGC	234;233;231	G;G;C	218;220;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1311	1313	GCA	235;235;235	G;C;A	220;218;219	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1314	1316	ATC	235;234;235	A;T,A;C	218;214,1;217	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1326	1328	GTG	228;225;223	G;T;G	216;210;212	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1326	1328	GTG	228;225;223	G;T;G	216;210;212	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1830	1832	ACC	236;237;238	A;C;C	221;223;222	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1884	1886	GCG	217;218;216	G;C;G	180;170;176	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1884	1886	GCG	217;218;216	G;C;G	180;170;176	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2007	2009	GGC	173;170;168	G;G;C	159;152;153	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2016	2018	GGC	162;161;164	G;G;C	147;145;151	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2462	174.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2034	2036	CCG	144;147;147	C,G;C;G	106,6;112;112	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6282	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3094	202.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2612	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1872	138.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	550	550	C	174	C	159	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	0	.	p	.	0	E48G	NONSYN	142	144	GAA	506	508	GGA	238;240;239	G;G,A;A	224;225,1;223	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	0	.	p	.	0	F135L	NONSYN	403	405	TTT	767	769	CTT	213;215;218	C;T;T	195;197;200	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	0	.	p	.	0	R143G	NONSYN	427	429	AGA	791	793	GGA	222;220;217	G;G,T;A	199;199,1;197	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	0	.	p	.	0	D171G	NONSYN	511	513	GAT	875	877	GGT	204;207;211	G;G;T	185;188;191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	0	.	p	.	0	G189S	NONSYN	565	567	GGC	929	931	AGC	222;221;220	A;G,T;C	206;205,1;200	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	995	995	T	187	T	177	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	1	SNP	p	G120K	0	.	.	358	360	GGT	722	724	GGT	192;197;201	G;G;T	176;182;183	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	1	SNP	p	A121N	0	.	.	361	363	GCC	725	727	GCC	201;200;201	G;C;C	185;185;185	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2716	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1630	165.8	1	SNP	p	A121D	0	.	.	361	363	GCC	725	727	GCC	201;200;201	G;C;C	185;185;185	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10960	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4786	228.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1995	1997	AAT	223;223;226	A;A,G;T	215;214,1;216	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1128	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1049	106.8	1	SNP	p	V57M	1	.	.	169	171	ATG	534	536	ATG	207;206;208	A;T;G,T	189;189;190,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
